Literature DB >> 9473637

Distribution of the alpha7 nicotinic acetylcholine receptor subunit in the developing chick cerebellum

.   

Abstract

Previous studies of the nicotinic acetylcholine receptor (nAChR) subunits in adult mammalian and avian brains have demonstrated a spatially restricted distribution of these subunits; little, however, is known about the nAChR subunit developmental distribution. The present study demonstrated a transient pattern of distribution of the neuronal nAChR subunit, alpha7, in the developing chick cerebellum by using immunohistochemical techniques. This transient distribution may suggest a critical period for the development of the cholinergic system in the cerebellum.

Entities:  

Year:  1998        PMID: 9473637

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  5 in total

1.  Reduction of neuromuscular activity is required for the rescue of motoneurons from naturally occurring cell death by nicotinic-blocking agents.

Authors:  R W Oppenheim; D Prevette; A D'Costa; S Wang; L J Houenou; J M McIntosh
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Effects of chronic neonatal nicotine exposure on nicotinic acetylcholine receptor binding, cell death and morphology in hippocampus and cerebellum.

Authors:  L Z Huang; L C Abbott; U H Winzer-Serhan
Journal:  Neuroscience       Date:  2007-04-16       Impact factor: 3.590

Review 3.  Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.

Authors:  Maryka Quik; Danhui Zhang; Matthew McGregor; Tanuja Bordia
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

4.  Acute synaptic modulation by nicotinic agonists in developing cerebellar Purkinje cells of the rat.

Authors:  Kazuyoshi Kawa
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

5.  Localization of CB1 cannabinoid receptor mRNA in the brain of the chick (Gallus domesticus).

Authors:  Todd L Stincic; Richard L Hyson
Journal:  Brain Res       Date:  2008-09-20       Impact factor: 3.252

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.